Future Screening Prospects for Ovarian Cancer
Current diagnostic tools used in clinical practice such as transvaginal ultrasound, CA 125, and HE4 are not sensitive and specific enough to diagnose OC in the early stages. A lack of early symptoms and an effective asymptomatic population screening strategy leads to a poor prognosis in OC. New diag...
Main Authors: | Diana Žilovič, Rūta Čiurlienė, Rasa Sabaliauskaitė, Sonata Jarmalaitė |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/15/3840 |
Similar Items
-
Uterine Cavity Lavage Mutation Analysis in Lithuanian Ovarian Cancer Patients
by: Diana Žilovič, et al.
Published: (2023-01-01) -
Novel Pathogenic Variants in Hereditary Cancer Syndromes in a Highly Heterogeneous Cohort of Patients: Insights from Multigene Analysis
by: Airat Bilyalov, et al.
Published: (2023-12-01) -
<i>ARID1A</i>, NOTCH and WNT Signature in Gynaecological Tumours
by: Ieva Vaicekauskaitė, et al.
Published: (2023-03-01) -
Application of Multigene Panels Testing for Hereditary Cancer Syndromes
by: Airat Bilyalov, et al.
Published: (2022-10-01) -
Multi-gene panel testing increases germline predisposing mutations’ detection in a cohort of breast/ovarian cancer patients from Southern Italy
by: Marcella Nunziato, et al.
Published: (2022-08-01)